β-glucan derived from zymosan acts as an adjuvant for collagen-induced arthritis

Microbiology and Immunology

Volumn 50, Issue 6, 2006, Pages 453-461

  Hida, Shunsuke ^a   Nagi Miura, Noriko ^a   Adachi, Yoshiyuki ^a   Ohno, Naohito ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Adjuvant; Collagen induced arthritis; Zymosan; Glucan

Indexed keywords

BETA GLUCAN; COLLAGEN; FREUND ADJUVANT; HYPOCHLORITE SODIUM; LIPOPOLYSACCHARIDE; OXIDIZING AGENT; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DISEASE SEVERITY; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG SYNTHESIS; INNATE IMMUNITY; MACROPHAGE; MALE; MEDICAL RESEARCH; MOUSE; NONHUMAN; OXIDATION; RHEUMATOID ARTHRITIS;

CANDIDA ALBICANS; MYCOBACTERIUM TUBERCULOSIS;

EID: 33745242490     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2006.tb03814.x     Document Type: Article

References (45)

1. Abbas, A.K., Murphy, K.M., and Sher, A. 1996. Functional diversity of helper T lymphocytes. Nature 383: 787-793.
2. Adachi, Y., Okazaki, M., Ohno, N., and Yadomae, T. 1994. Enhancement of cytokine production by macrophages stimulated with (1.3)-beta-D-glucan, grifolan (GRN), isolated from Grifola frondosa. Biol. Pharm. Bull. 17: 1554-1560.
3. Bannwarth, B., Labat, L., Moride, Y., and Schaeverbeke, T. 1994. Methotrexate in rheumatoid arthritis. An update. Drugs 47: 25-50.
4. Bellet, J.S., and Prose, N.S. 2005. Skin complications of Bacillus Calmette-Guerin immunization. Curr. Opin. Infect. Dis. 18: 97-100.
5. Berton, M.T., Uhr, J.W., and Vitetta, E.S. 1989. Synthesis of germ-line gamma 1 immunoglobulin heavy-chain transcripts in resting B cells: induction by interleukin 4 and inhibition by interferon gamma. Proc. Natl. Acad. Sci. U.S.A. 86: 2829-2833.
6. Bookbinder, S.A., Espinoza, L.R., Fenske, N.A., Germain, B.F., and Vasey, F.B. 1984. Methotrexate: its use in the rheumatic diseases. Clin. Exp. Rheumatol. 2: 185-193.
7. Bresnihan, B., Alvaro-Gracia, J.M., Cobby, M., Doherty, M., Domljan, Z., Emery, P., Nuki, G., Pavelka, K., Rau, R., Rozman, B., Watt, I., Williams, B., Aitchison, R., McCabe, D., and Musikic, P. 1998. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum. 41: 2196-2204.
8. Choy, E.H., and Panayi, G.S. 2001. Cytokine pathways and joint inflammation in rheumatoid arthritis. N. Engl. J. Med. 344: 907-916.
9. Chu, C.Q., and Londei, M. 1996. Induction of Th2 cytokines and control of collagen-induced arthritis by non-depleting anti-CD4 Abs. J. Immunol. 157: 2685-2689.
10. Courtenay, J.S., Dallman, M.J., Dayan, A.D., Martin, A., and Mosedale, B. 1980. Immunisation against heterologous type II collagen induces arthritis in mice. Nature 283: 666-668.
11. Czop, J.K. 1986. The role of beta-glucan receptors on blood and tissue leukocytes in phagocytosis and metabolic activation. Pathol. Immunopathol. Res. 5: 286-296.
12. Daoud, K.F., Jackson, C.G., and Williams, H.J. 1999. Basic therapy for rheumatoid arthritis: nonsteroidal anti-inflammatory drugs. Compr. Ther. 25: 427-433.
13. Di Carlo, F.J., and Fiore, J.V. 1958. On the composition of zymosan. Science 127: 756-757.
14. Elliott, M.J., Maini, R.N., Feldmann, M., Long-Fox, A., Charles, P., Katsikis, P., Brennan, F.M., Walker, J., Bijl, H., Ghrayeb, J., and Woody, J.N. 1993. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum. 36: 1681-1690.
15. Fearon, D.T., and Austen, K.F. 1977. Activation of the alternative complement pathway due to resistance of zymosan-bound. Proc. Natl. Acad. Sci. U.S.A. 74: 1683-1687.
16. Finkelman, F.D., Katona, I.M., Mosmann, T.R., and Coffman, R.L. 1988. IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses. J. Immunol. 140: 1022-1027.
17. Hannum, C.H., Wilcox, C.J., Arend, W.P., Joslin, F.G., Dripps, D.J., Heimdal, P.L., Armes, L.G., Sommer, A., Eisenberg, S.P., and Thompson, R.C. 1990. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343: 336-340.
18. Hashimoto, T., Ohno, N., Adachi, Y., and Yadomae, T. 1997. Nitric oxide synthesis in murine peritoneal macrophages by fungal beta-glucans. Biol. Pharm. Bull. 20: 1006-1009.
19. Hida, S., Miura, N.N., Adachi, Y., and Ohno, N. 2005. Effect of Candida albicans cell wall glucan as adjuvant for induction of autoimmune arthritis in mice. J. Autoimmun. 25: 93-101.
20. Ikeda, Y., Adachi, Y., Ishibashi, K., Miura, N., and Ohno, N. 2005. Activation of toll-like receptor-mediated NF-kappa beta by zymosan-derived water-soluble fraction: possible contribution of endotoxin-like substances. Immunopharmacol. Immunotoxicol. 27: 285-298.
21. Ishibashi, K., Miura, N.N., Adachi, Y., Ogura, N., Tamura, H., Tanaka, S., and Ohno, N. 2002. Relationship between the physical properties of Candida albicans cell wall beta-glucan and activation of leukocytes in vitro. Int. Immunopharmacol. 2: 1109-1122.
22. Ishibashi, K., Miura, N.N., Adachi, Y., Ogura, N., Tamura, H., Tanaka, S., and Ohno, N. 2004. DNA array analysis of altered gene expression in human leukocytes stimulated with soluble and particulate forms of Candida cell wall beta-glucan. Int. Immunopharmacol. 4: 387-401.
23. Mauri, C., Williams, R.O., Walmsley, M., and Feldmann, M. 1996. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur. J. Immunol. 26: 1511-1518.
24. Miura, N.N., Ohno, N., Adachi, Y., and Yadomae, T. 1996. Characterization of sodium hypochlorite degradation of beta-glucan in relation to its metabolism in vivo. Chem. Pharm. Bull. (Tokyo) 44: 2137-2141.
25. Miura, T., Ohno, N., Miura, N.N., Adachi, Y., Shimada, S., and Yadomae, T. 1999. Antigen-specific response of murine immune system toward a yeast beta-glucan preparation, zymosan. FEMS Immunol. Med. Microbiol. 24: 131-139.
26. Moreland, L.W., Baumgartner, S.W., Schiff, M.H., Tindall, E.A., Fleischmann, R.M., Weaver, A.L., Ettlinger, R.E., Cohen, S., Koopman, W.J., Mohler, K., Widmer, M.B., and Blosch, C.M. 1997. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N. Engl. J. Med. 337: 141-147.
27. Mosmann, T.R., Cherwinski, H., Bond, M.W., Giedlin, M.A., and Coffman, R.L. 2005. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. 1986. J. Immunol. 175: 5-14.
28. Mussener, A., Lorentzen, J.C., Kleinau, S., and Klareskog, L. 1997. Altered Th1/Th2 balance associated with non-major histocompatibility complex genes in collagen-induced arthritis in resistant and non-resistant rat strains. Eur. J. Immunol. 27: 695-699.
29. Myers, L.K., Rosloniec, E.F., Cremer, M.A., and Kang, A.H. 1997. Collagen-induced arthritis, an animal model of autoimmunity. Life Sci. 61: 1861-1878.
30. Nishimoto, N., Kishimoto, T., and Yoshizaki, K. 2000. Anti-interleukin 6 receptor antibody treatment in rheumatic disease. Ann. Rheum. Dis. 59 (Suppl 1): i21-i27.
31. Ohno, N., Miura, T., Miura, N.N., Adachi, Y., and Yadomae, T. 2001. Structure and biological activities of hypochlorite oxidized zymosancarbohydrate polymers. Carbohydr. Polym. 44: 339-349.
32. Ohno, N., Miura, T., Miura, N.N., Chiba, N., Uchiyama, M., Adachi, Y., and Yadomae, T. 1999. Inflammatory and immunopharmacological activities of meta-periodate oxidized zymosan. Zentralbl. Bakteriol. 289: 63-77.
33. Ohno, N., Uchiyama, M., Tsuzuki, A., Tokunaka, K., Miura, N.N., Adachi, Y., Aizawa, M.W., Tamura, H., Tanaka, S., and Yadomae, T. 1999. Solubilization of yeast cell-wall beta-(1.3)-D-glucan by sodium hypochlorite oxidation and dimethyl sulfoxide extraction. Carbohydr. Res. 316: 161-172.
34. Okazaki, M., Adachi, Y., Ohno, N., and Yadomae, T. 1995. Structure-activity relationship of (1→3)-beta-D-glucans in the induction of cytokine production from macrophages, in vitro. Biol. Pharm. Bull. 18: 1320-1327.
35. Ozinsky, A., Underhill, D.M., Fontenot, J.D., Hajjar, A.M., Smith, K.D., Wilson, C.B., Schroeder, L., and Aderem, A. 2000. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl. Acad. Sci. U.S.A. 97: 13766-13771.
36. Shepherd, M.G., and Sullivan, P.A. 1976. The production and growth characteristics of yeast and mycelial forms of Candida albicans in continuous culture. J. Gen. Microbiol. 93: 361-370.
37. Snapper, C.M., Peschel, C., and Paul, W.E. 1988. IFN-gamma stimulates IgG2a secretion by murine B cells stimulated with bacterial lipopolysaccharide. J. Immunol. 140: 2121-2127.
38. Trentham, D.E., Townes, A.S., and Kang, A.H. 1977. Autoimmunity to type II collagen: an experimental model of arthritis. J. Exp. Med. 146: 857-868.
39. Underhill, D.M., Ozinsky, A., Hajjar, A.M., Stevens, A., Wilson, C.B., Bassetti, M., and Aderem, A. 1999. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401: 811-815.
40. Vassallo, R., Standing, J.E., and Limper, A.H. 2000. Isolated Pneumocystis carinii cell wall glucan provokes lower respiratory tract inflammatory responses. J. Immunol. 164: 3755-3763.
41. Williams, R.O., Feldmann, M., and Maini, R.N. 1992. Antitumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. U.S.A. 89: 9784-9788.
42. Yadomae, T. 2000. Structure and biological activities of fungal beta-1,3-glucans. Yakugaku Zasshi 120: 413-431.
43. Yoshino, S., and Ohsawa, M. 2000. The role of lipopolysaccharide injected systemically in the reactivation of collagen-induced arthritis in mice. Br. J. Pharmacol. 129: 1309-1314.
44. Yoshino, S., Sasatomi, E., Mori, Y., and Sagai, M. 1999. Oral administration of lipopolysaccharide exacerbates collagen-induced arthritis in mice. J. Immunol. 163: 3417-3422.
45. Yoshino, S., Sasatomi, E., and Ohsawa, M. 2000. Bacterial lipopolysaccharide acts as an adjuvant to induce autoimmune arthritis in mice. Immunology 99: 607-614.